BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine DependenceCocaine AbuseCocaine AddictionSubstance Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT01651364
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg
Not Applicable
Withdrawn
- Conditions
- Pain, Sciatic Block
- Interventions
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT01641419
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)
Not Applicable
Completed
- Conditions
- Citrullinemia
- Interventions
- Other: stable isotope infusion
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT01610089
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Phase 1
Terminated
- Conditions
- B-cell Chronic Lymphocytic Leukemia
- Interventions
- Biological: B-CLL Vaccine
- First Posted Date
- 2012-05-23
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT01604031
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Exercise as a Behavioral Treatment for Cocaine Dependence
Not Applicable
Completed
- Conditions
- Cocaine AbuseCocaine DependenceCocaine AddictionSubstance Abuse
- Interventions
- Behavioral: WalkingBehavioral: SittingBehavioral: Running
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT01601743
- Locations
- 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
Modafinil - Escitalopram Study for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine DependenceCocaine AbuseCocaine AddictionSubstance Abuse
- Interventions
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 68
- Registration Number
- NCT01601730
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
RTI-336 as a Treatment for Methamphetamine Dependence
Phase 1
Withdrawn
- Conditions
- Methamphetamine DependenceSubstance AbuseMethamphetamine Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT01601717
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT01582568
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Varenicline as a Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Methamphetamine DependenceMethamphetamine AbuseSubstance Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT01571167
- Locations
- 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Phase 1
Recruiting
- Conditions
- LymphomaNon-Hodgkin's LymphomaLymphoproliferative DiseaseHodgkin's Disease
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 136
- Registration Number
- NCT01555892
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath